“Addition of Daratumumab to First-Line Therapy of Newly Diagnosed Multiple Myeloma in Patients Eligible for Autologous Stem Cell Transplantation: A Single-Center Real-Life Experience”. Mediterranean Journal of Hematology and Infectious Diseases 17, no. 1 (April 30, 2025): e2025040. Accessed April 30, 2026. https://www.mjhid.org/mjhid/article/view/5995.